Comparison of 3 Upper Tract Anticarcinogenic Agent Delivery Techniques in an Ex Vivo Porcine Model

Objective To evaluate the degree of urothelial exposure using 3 upper tract delivery techniques in an ex vivo porcine model, to determine the optimal modality to locally deliver topical anticarcinogenic agents in patients with upper tract urothelial carcinoma. Materials and Methods An indigo carmine...

Full description

Saved in:
Bibliographic Details
Published inUrology (Ridgewood, N.J.) Vol. 82; no. 6; pp. 1451.e1 - 1451.e6
Main Authors Pollard, Matthew E, Levinson, Adam W, Shapiro, Edan Y, Cha, Doh Y, Small, Alex C, Mohamed, Nihal E, Badani, Ketan K, Gupta, Mantu
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.12.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Objective To evaluate the degree of urothelial exposure using 3 upper tract delivery techniques in an ex vivo porcine model, to determine the optimal modality to locally deliver topical anticarcinogenic agents in patients with upper tract urothelial carcinoma. Materials and Methods An indigo carmine solution was infused into en bloc porcine urinary tracts to test the 3 techniques: antegrade infusion via nephrostomy tube, reflux via indwelling double-pigtail stent, and retrograde administration via a 5F open-ended ureteral catheter. Nine renal units (3 per delivery method) were used. After a 1-hour dwell time, the urinary tracts were bivalved and photographed. Each renal unit was evaluated by 3 blinded reviewers who estimated the total percentage of stained urothelial surface area using a computer-based area approximation system. In addition, as a surrogate for exposure adequacy, a validated equation was used to calculate the staining intensity at 6 predetermined locations in the upper tract, with lower values representing more efficient staining. Results Mean percent of surface area stained for the nephrostomy tube, double-pigtail stent, and open-ended ureteral catheter groups was 65.2%, 66.2%, and 83.6%, respectively ( P  = .002). Mean staining intensities were 40.9, 33.4, and 20.4, respectively ( P  = .023). Conclusion Our results suggest that retrograde infusion via open-ended ureteral catheter is the most efficient method of upper tract therapy delivery. Larger studies using in vivo models should be performed to further validate these findings and potentially confirm this method as optimal for delivery of topical anticarcinogenic agents in upper tract urothelial carcinoma.
AbstractList To evaluate the degree of urothelial exposure using 3 upper tract delivery techniques in an ex vivo porcine model, to determine the optimal modality to locally deliver topical anticarcinogenic agents in patients with upper tract urothelial carcinoma. An indigo carmine solution was infused into en bloc porcine urinary tracts to test the 3 techniques: antegrade infusion via nephrostomy tube, reflux via indwelling double-pigtail stent, and retrograde administration via a 5F open-ended ureteral catheter. Nine renal units (3 per delivery method) were used. After a 1-hour dwell time, the urinary tracts were bivalved and photographed. Each renal unit was evaluated by 3 blinded reviewers who estimated the total percentage of stained urothelial surface area using a computer-based area approximation system. In addition, as a surrogate for exposure adequacy, a validated equation was used to calculate the staining intensity at 6 predetermined locations in the upper tract, with lower values representing more efficient staining. Mean percent of surface area stained for the nephrostomy tube, double-pigtail stent, and open-ended ureteral catheter groups was 65.2%, 66.2%, and 83.6%, respectively (P = .002). Mean staining intensities were 40.9, 33.4, and 20.4, respectively (P = .023). Our results suggest that retrograde infusion via open-ended ureteral catheter is the most efficient method of upper tract therapy delivery. Larger studies using in vivo models should be performed to further validate these findings and potentially confirm this method as optimal for delivery of topical anticarcinogenic agents in upper tract urothelial carcinoma.
To evaluate the degree of urothelial exposure using 3 upper tract delivery techniques in an ex vivo porcine model, to determine the optimal modality to locally deliver topical anticarcinogenic agents in patients with upper tract urothelial carcinoma. An indigo carmine solution was infused into en bloc porcine urinary tracts to test the 3 techniques: antegrade infusion via nephrostomy tube, reflux via indwelling double-pigtail stent, and retrograde administration via a 5F open-ended ureteral catheter. Nine renal units (3 per delivery method) were used. After a 1-hour dwell time, the urinary tracts were bivalved and photographed. Each renal unit was evaluated by 3 blinded reviewers who estimated the total percentage of stained urothelial surface area using a computer-based area approximation system. In addition, as a surrogate for exposure adequacy, a validated equation was used to calculate the staining intensity at 6 predetermined locations in the upper tract, with lower values representing more efficient staining. Mean percent of surface area stained for the nephrostomy tube, double-pigtail stent, and open-ended ureteral catheter groups was 65.2%, 66.2%, and 83.6%, respectively (P = .002). Mean staining intensities were 40.9, 33.4, and 20.4, respectively (P = .023). Our results suggest that retrograde infusion via open-ended ureteral catheter is the most efficient method of upper tract therapy delivery. Larger studies using in vivo models should be performed to further validate these findings and potentially confirm this method as optimal for delivery of topical anticarcinogenic agents in upper tract urothelial carcinoma.
Objective To evaluate the degree of urothelial exposure using 3 upper tract delivery techniques in an ex vivo porcine model, to determine the optimal modality to locally deliver topical anticarcinogenic agents in patients with upper tract urothelial carcinoma. Materials and Methods An indigo carmine solution was infused into en bloc porcine urinary tracts to test the 3 techniques: antegrade infusion via nephrostomy tube, reflux via indwelling double-pigtail stent, and retrograde administration via a 5F open-ended ureteral catheter. Nine renal units (3 per delivery method) were used. After a 1-hour dwell time, the urinary tracts were bivalved and photographed. Each renal unit was evaluated by 3 blinded reviewers who estimated the total percentage of stained urothelial surface area using a computer-based area approximation system. In addition, as a surrogate for exposure adequacy, a validated equation was used to calculate the staining intensity at 6 predetermined locations in the upper tract, with lower values representing more efficient staining. Results Mean percent of surface area stained for the nephrostomy tube, double-pigtail stent, and open-ended ureteral catheter groups was 65.2%, 66.2%, and 83.6%, respectively ( P  = .002). Mean staining intensities were 40.9, 33.4, and 20.4, respectively ( P  = .023). Conclusion Our results suggest that retrograde infusion via open-ended ureteral catheter is the most efficient method of upper tract therapy delivery. Larger studies using in vivo models should be performed to further validate these findings and potentially confirm this method as optimal for delivery of topical anticarcinogenic agents in upper tract urothelial carcinoma.
OBJECTIVETo evaluate the degree of urothelial exposure using 3 upper tract delivery techniques in an ex vivo porcine model, to determine the optimal modality to locally deliver topical anticarcinogenic agents in patients with upper tract urothelial carcinoma.MATERIALS AND METHODSAn indigo carmine solution was infused into en bloc porcine urinary tracts to test the 3 techniques: antegrade infusion via nephrostomy tube, reflux via indwelling double-pigtail stent, and retrograde administration via a 5F open-ended ureteral catheter. Nine renal units (3 per delivery method) were used. After a 1-hour dwell time, the urinary tracts were bivalved and photographed. Each renal unit was evaluated by 3 blinded reviewers who estimated the total percentage of stained urothelial surface area using a computer-based area approximation system. In addition, as a surrogate for exposure adequacy, a validated equation was used to calculate the staining intensity at 6 predetermined locations in the upper tract, with lower values representing more efficient staining.RESULTSMean percent of surface area stained for the nephrostomy tube, double-pigtail stent, and open-ended ureteral catheter groups was 65.2%, 66.2%, and 83.6%, respectively (P = .002). Mean staining intensities were 40.9, 33.4, and 20.4, respectively (P = .023).CONCLUSIONOur results suggest that retrograde infusion via open-ended ureteral catheter is the most efficient method of upper tract therapy delivery. Larger studies using in vivo models should be performed to further validate these findings and potentially confirm this method as optimal for delivery of topical anticarcinogenic agents in upper tract urothelial carcinoma.
Author Gupta, Mantu
Cha, Doh Y
Pollard, Matthew E
Small, Alex C
Badani, Ketan K
Levinson, Adam W
Shapiro, Edan Y
Mohamed, Nihal E
Author_xml – sequence: 1
  fullname: Pollard, Matthew E
– sequence: 2
  fullname: Levinson, Adam W
– sequence: 3
  fullname: Shapiro, Edan Y
– sequence: 4
  fullname: Cha, Doh Y
– sequence: 5
  fullname: Small, Alex C
– sequence: 6
  fullname: Mohamed, Nihal E
– sequence: 7
  fullname: Badani, Ketan K
– sequence: 8
  fullname: Gupta, Mantu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24139525$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1u1DAUhS1URKeFRwB5ySbh-i9xNqDRUFqkIpCYsrVc507xkLGDnYyYt-FZeDISzcCCDauzOefee757Qc5CDEjIcwYlA1a92pZjil18OJQcmChBlyD1I7JgitdF0zTqjCwAGigkb9Q5uch5CwBVVdVPyDmXTDSKqwVxq7jrbfI5Bho3VNC7vsdE18m6gS7D4J1Nzof4gME7upxkoG-x83tMB7pG9zX47yNm6gO1gV79-PXzi99H-inOKaQfYovdU_J4Y7uMz056Se7eXa1XN8Xtx-v3q-Vt4SSHoVBCNIj3Em0rdM21rbGSdeVaLaY6snJOMasqVTttW-SoLNQahNuoVtagKnFJXh7n9inORw1m57PDrrMB45gNk5XUWjcgJ6s6Wl2KOSfcmD75nU0Hw8DMfM3WnPiama8BbSa-U-7FacV4v8P2b-oP0Mnw5mjAqejeYzLZeQwOW5_QDaaN_r8rXv8zwXV-gm-7b3jAvI1jChNFw0zmBszn-cnzj5kAxgRn4jcLVKX0
CitedBy_id crossref_primary_10_1590_s1677_5538_ibju_2016_0258
crossref_primary_10_1016_j_urology_2018_02_004
crossref_primary_10_3389_fruro_2022_916259
crossref_primary_10_1007_s00120_018_0830_0
crossref_primary_10_1016_j_urology_2016_09_039
crossref_primary_10_1080_17512433_2018_1461560
crossref_primary_10_1007_s00345_019_02811_w
crossref_primary_10_1089_end_2016_0871
crossref_primary_10_1016_j_urolonc_2019_02_004
crossref_primary_10_1016_j_urolonc_2020_08_002
crossref_primary_10_1089_end_2020_0293
crossref_primary_10_1080_14737140_2017_1326823
crossref_primary_10_1016_j_ucl_2017_12_009
crossref_primary_10_3233_BLC_220093
Cites_doi 10.1002/1097-0142(19850315)55:6<1422::AID-CNCR2820550642>3.0.CO;2-F
10.1016/j.eururo.2011.07.051
10.1046/j.1464-410X.2001.02297.x
10.1089/end.2007.9969
10.1016/j.eururo.2010.12.042
10.1046/j.1464-410x.2000.00610.x
10.1016/j.eururo.2004.01.021
10.1046/j.1464-410X.1996.09559.x
10.1016/j.urology.2004.01.046
10.1016/S0090-4295(99)80005-3
10.1191/096228000701555262
10.1038/ncpuro0250
10.1111/j.1442-2042.2006.01312.x
10.1016/j.eururo.2011.03.017
10.1016/j.urology.2008.06.026
10.1016/S0090-4295(01)01488-1
10.1111/j.1464-410X.2012.11066.x
10.1046/j.1442-2042.2002.00551.x
ContentType Journal Article
Copyright Elsevier Inc.
2013 Elsevier Inc.
Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright_xml – notice: Elsevier Inc.
– notice: 2013 Elsevier Inc.
– notice: Copyright © 2013 Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.urology.2013.08.048
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1527-9995
EndPage 1451.e6
ExternalDocumentID 10_1016_j_urology_2013_08_048
24139525
S0090429513011321
1_s2_0_S0090429513011321
Genre Journal Article
Comparative Study
GroupedDBID ---
--K
--M
-RU
.1-
.55
.FO
.GJ
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
29Q
3O-
4.4
457
4CK
4G.
53G
5RE
5VS
6PF
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAEJM
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQQT
AAQXK
AAWTL
AAXKI
AAXUO
ABBQC
ABFNM
ABLJU
ABMAC
ABMZM
ABOCM
ABXDB
ACDAQ
ACIUM
ACRLP
ACRZS
ADBBV
ADEZE
ADMUD
AEBSH
AEKER
AENEX
AEVXI
AFCTW
AFFNX
AFJKZ
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJJEV
AJOXV
AJRQY
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEA
HMK
HMO
HVGLF
HZ~
IHE
J1W
KOM
L7B
LZ2
M29
M41
MO0
N9A
O-L
O9-
OAUVE
OK.
OW.
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SPCBC
SSH
SSZ
T5K
UV1
WH7
WOW
WUQ
X7M
XPP
Z5R
ZGI
~G-
AAIAV
ABLVK
ABYKQ
AHPSJ
AJBFU
EFLBG
LCYCR
ZA5
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c420t-5339eeb4ead38728a7e6476cd8399546cc51a5657c8ade2e5a07803cf5d470563
IEDL.DBID AIKHN
ISSN 0090-4295
IngestDate Fri Oct 25 22:52:56 EDT 2024
Thu Sep 26 18:39:00 EDT 2024
Sat Sep 28 07:52:57 EDT 2024
Fri Feb 23 02:27:29 EST 2024
Tue Oct 15 22:55:32 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License Copyright © 2013 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c420t-5339eeb4ead38728a7e6476cd8399546cc51a5657c8ade2e5a07803cf5d470563
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 24139525
PQID 1464888904
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1464888904
crossref_primary_10_1016_j_urology_2013_08_048
pubmed_primary_24139525
elsevier_sciencedirect_doi_10_1016_j_urology_2013_08_048
elsevier_clinicalkeyesjournals_1_s2_0_S0090429513011321
PublicationCentury 2000
PublicationDate 2013-12-01
PublicationDateYYYYMMDD 2013-12-01
PublicationDate_xml – month: 12
  year: 2013
  text: 2013-12-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Urology (Ridgewood, N.J.)
PublicationTitleAlternate Urology
PublicationYear 2013
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Treuthardt, Danuser, Studer (bib28) 2004; 46
Rastinehad, Ost, Vanderbrink (bib8) 2009; 73
Vasavada, Streem, Novick (bib6) 1995; 45
Hayashida, Nomata, Noguchi (bib12) 2004; 63
Nelson, Pepe (bib21) 2000; 9
Huffman, Bagley, Lyon (bib2) 1985; 15
Kojima, Tozawa, Kawai (bib15) 2006; 13
Nishino, Yamamoto, Komeda (bib18) 2000; 85
Hall, Chang, Dalbagni (bib25) 2007; 178
Jarrett, Sweetser, Weiss (bib5) 1995; 154
Monson, Wein, McKenna (bib30) 1991; 145
Guarnizo, Pavlovich, Seiba (bib22) 2000; 163
Roupret, Zigeuner, Palou (bib1) 2011; 59
Miyake, Eto, Hara (bib11) 2002; 9
Huffman, Morse, Herr (bib4) 1985; 26
Yokogi, Wada, Mizutani (bib10) 1996; 77
Grasso, Fishman, Cohen (bib24) 2012; 110
Pereira-Sampaio, Favorito, Sampaio (bib19) 2004; 172
Schnapp, Weiss, Smith (bib29) 1996; 156
Gadzinski, Roberts, Faerber (bib23) 2010; 183
Babjuk, Oosterlinck, Sylvester (bib26) 2011; 59
Ost, Vanderbrink, Lee (bib3) 2005; 2
Yossepowitch, Lifshitz, Dekel (bib27) 2005; 173
Thalmann, Markwalder, Walter (bib7) 2002; 168
Katz, Lee, Gupta (bib17) 2007; 21
Giannarini, Kessler, Birkhauser (bib9) 2011; 60
Patel, Fuchs (bib13) 1998; 159
Bass (bib20) 2010
Okubo, Ichioka, Terada (bib16) 2001; 88
Irie, Iwamura, Kadowaki (bib14) 2002; 59
Yokogi (10.1016/j.urology.2013.08.048_bib10) 1996; 77
Kojima (10.1016/j.urology.2013.08.048_bib15) 2006; 13
Roupret (10.1016/j.urology.2013.08.048_bib1) 2011; 59
Hall (10.1016/j.urology.2013.08.048_bib25) 2007; 178
Monson (10.1016/j.urology.2013.08.048_bib30) 1991; 145
Nishino (10.1016/j.urology.2013.08.048_bib18) 2000; 85
Giannarini (10.1016/j.urology.2013.08.048_bib9) 2011; 60
Nelson (10.1016/j.urology.2013.08.048_bib21) 2000; 9
Katz (10.1016/j.urology.2013.08.048_bib17) 2007; 21
Babjuk (10.1016/j.urology.2013.08.048_bib26) 2011; 59
Gadzinski (10.1016/j.urology.2013.08.048_bib23) 2010; 183
Treuthardt (10.1016/j.urology.2013.08.048_bib28) 2004; 46
Rastinehad (10.1016/j.urology.2013.08.048_bib8) 2009; 73
Grasso (10.1016/j.urology.2013.08.048_bib24) 2012; 110
Thalmann (10.1016/j.urology.2013.08.048_bib7) 2002; 168
Schnapp (10.1016/j.urology.2013.08.048_bib29) 1996; 156
Yossepowitch (10.1016/j.urology.2013.08.048_bib27) 2005; 173
Huffman (10.1016/j.urology.2013.08.048_bib2) 1985; 15
Patel (10.1016/j.urology.2013.08.048_bib13) 1998; 159
Bass (10.1016/j.urology.2013.08.048_bib20) 2010
Irie (10.1016/j.urology.2013.08.048_bib14) 2002; 59
Vasavada (10.1016/j.urology.2013.08.048_bib6) 1995; 45
Pereira-Sampaio (10.1016/j.urology.2013.08.048_bib19) 2004; 172
Ost (10.1016/j.urology.2013.08.048_bib3) 2005; 2
Miyake (10.1016/j.urology.2013.08.048_bib11) 2002; 9
Huffman (10.1016/j.urology.2013.08.048_bib4) 1985; 26
Hayashida (10.1016/j.urology.2013.08.048_bib12) 2004; 63
Guarnizo (10.1016/j.urology.2013.08.048_bib22) 2000; 163
Jarrett (10.1016/j.urology.2013.08.048_bib5) 1995; 154
Okubo (10.1016/j.urology.2013.08.048_bib16) 2001; 88
References_xml – volume: 9
  start-page: 677
  year: 2002
  end-page: 680
  ident: bib11
  article-title: Clinical outcome of bacillus Calmette-Guerin perfusion therapy for carcinoma in situ of the upper urinary tract
  publication-title: Int J Urol
  contributor:
    fullname: Hara
– volume: 45
  start-page: 381
  year: 1995
  end-page: 386
  ident: bib6
  article-title: Definitive tumor resection and percutaneous bacille Calmette-Guerin for management of renal pelvic transitional cell carcinoma in solitary kidneys
  publication-title: Urology
  contributor:
    fullname: Novick
– volume: 178
  start-page: 2314
  year: 2007
  end-page: 2330
  ident: bib25
  article-title: Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update
  publication-title: J Urol
  contributor:
    fullname: Dalbagni
– volume: 21
  start-page: 374
  year: 2007
  end-page: 377
  ident: bib17
  article-title: Setting a new standard for topical therapy of upper-tract transitional-cell carcinoma: BCG and interferon-alpha2B
  publication-title: J Endourol
  contributor:
    fullname: Gupta
– volume: 63
  start-page: 1084
  year: 2004
  end-page: 1088
  ident: bib12
  article-title: Long-term effects of bacille Calmette-Guerin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract
  publication-title: Urology
  contributor:
    fullname: Noguchi
– volume: 88
  start-page: 343
  year: 2001
  end-page: 347
  ident: bib16
  article-title: Intrarenal bacillus Calmette-Guerin therapy for carcinoma in situ of the upper urinary tract: long-term follow-up and natural course in cases of failure
  publication-title: BJU Int
  contributor:
    fullname: Terada
– volume: 183
  start-page: 2148
  year: 2010
  end-page: 2153
  ident: bib23
  article-title: Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma
  publication-title: J Urol
  contributor:
    fullname: Faerber
– year: 2010
  ident: bib20
  article-title: Handbook of Optics Volume III - Vision and Vision Optics: Chapter 10: Colorimetry
  contributor:
    fullname: Bass
– volume: 59
  start-page: 53
  year: 2002
  end-page: 57
  ident: bib14
  article-title: Intravesical instillation of bacille Calmette-Guerin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter
  publication-title: Urology
  contributor:
    fullname: Kadowaki
– volume: 13
  start-page: 340
  year: 2006
  end-page: 344
  ident: bib15
  article-title: Long-term outcome of upper urinary tract carcinoma in situ: effectiveness of nephroureterectomy versus bacillus Calmette-Guerin therapy
  publication-title: Int J Urol
  contributor:
    fullname: Kawai
– volume: 156
  start-page: 386
  year: 1996
  end-page: 388
  ident: bib29
  article-title: Fever following intracavitary bacillus Calmette-Guerin therapy for upper tract transitional cell carcinoma
  publication-title: J Urol
  contributor:
    fullname: Smith
– volume: 2
  start-page: 376
  year: 2005
  end-page: 383
  ident: bib3
  article-title: Endourologic treatment of upper urinary tract transitional cell carcinoma
  publication-title: Nat Clin Pract Urol
  contributor:
    fullname: Lee
– volume: 172
  start-page: 2077
  year: 2004
  end-page: 2081
  ident: bib19
  article-title: Pig kidney: anatomical relationships between the intrarenal arteries and the kidney collecting system. applied study for urological research and surgical training
  publication-title: J Urol
  contributor:
    fullname: Sampaio
– volume: 154
  start-page: 1629
  year: 1995
  end-page: 1635
  ident: bib5
  article-title: Percutaneous management of transitional cell carcinoma of the renal collecting system: 9-year experience
  publication-title: J Urol
  contributor:
    fullname: Weiss
– volume: 15
  start-page: 1422
  year: 1985
  end-page: 1428
  ident: bib2
  article-title: Endoscopic diagnosis and treatment of upper-tract urothelial tumors. A preliminary report
  publication-title: Cancer
  contributor:
    fullname: Lyon
– volume: 46
  start-page: 442
  year: 2004
  end-page: 443
  ident: bib28
  article-title: Tumor seeding following percutaneous antegrade treatment of transitional cell carcinoma in the renal pelvis
  publication-title: Eur Urol
  contributor:
    fullname: Studer
– volume: 77
  start-page: 676
  year: 1996
  end-page: 679
  ident: bib10
  article-title: Bacillus Calmette-Guerin perfusion therapy for carcinoma in situ of the upper urinary tract
  publication-title: Br J Urol
  contributor:
    fullname: Mizutani
– volume: 59
  start-page: 997
  year: 2011
  end-page: 1008
  ident: bib26
  article-title: EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update
  publication-title: Eur Urol
  contributor:
    fullname: Sylvester
– volume: 145
  start-page: 842
  year: 1991
  end-page: 845
  ident: bib30
  article-title: Indigocarmine as a quantitative indicator of urothelial integrity
  publication-title: J Urol
  contributor:
    fullname: McKenna
– volume: 26
  start-page: 47
  year: 1985
  end-page: 50
  ident: bib4
  article-title: Consideration for treatment of upper urinary tract tumors with topical therapy
  publication-title: Urology
  contributor:
    fullname: Herr
– volume: 60
  start-page: 955
  year: 2011
  end-page: 960
  ident: bib9
  article-title: Antegrade perfusion with bacillus Calmette-Guerin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit?
  publication-title: Eur Urol
  contributor:
    fullname: Birkhauser
– volume: 168
  start-page: 1381
  year: 2002
  end-page: 1385
  ident: bib7
  article-title: Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery
  publication-title: J Urol
  contributor:
    fullname: Walter
– volume: 73
  start-page: 27
  year: 2009
  end-page: 31
  ident: bib8
  article-title: A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus Calmette Guerin therapy?
  publication-title: Urology
  contributor:
    fullname: Vanderbrink
– volume: 163
  start-page: 52
  year: 2000
  end-page: 55
  ident: bib22
  article-title: Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach
  publication-title: J Urol
  contributor:
    fullname: Seiba
– volume: 9
  start-page: 475
  year: 2000
  end-page: 496
  ident: bib21
  article-title: Statistical description of interrater variability in ordinal ratings
  publication-title: Stat Methods Med Res
  contributor:
    fullname: Pepe
– volume: 159
  start-page: 71
  year: 1998
  end-page: 75
  ident: bib13
  article-title: New techniques for the administration of topical adjuvant therapy after endoscopic ablation of upper urinary tract transitional cell carcinoma
  publication-title: J Urol
  contributor:
    fullname: Fuchs
– volume: 110
  start-page: 1618
  year: 2012
  end-page: 1626
  ident: bib24
  article-title: Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients
  publication-title: BJU Int
  contributor:
    fullname: Cohen
– volume: 173
  start-page: 890
  year: 2005
  end-page: 893
  ident: bib27
  article-title: Assessment of vesicoureteral reflux in patients with self-retaining ureteral stents: implications for upper urinary tract instillation
  publication-title: J Urol
  contributor:
    fullname: Dekel
– volume: 85
  start-page: 799
  year: 2000
  end-page: 801
  ident: bib18
  article-title: Bacillus Calmette-Guerin instillation treatment for carcinoma in situ of the upper urinary tract
  publication-title: BJU Int
  contributor:
    fullname: Komeda
– volume: 59
  start-page: 584
  year: 2011
  end-page: 594
  ident: bib1
  article-title: European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update
  publication-title: Eur Urol
  contributor:
    fullname: Palou
– volume: 15
  start-page: 1422
  year: 1985
  ident: 10.1016/j.urology.2013.08.048_bib2
  article-title: Endoscopic diagnosis and treatment of upper-tract urothelial tumors. A preliminary report
  publication-title: Cancer
  doi: 10.1002/1097-0142(19850315)55:6<1422::AID-CNCR2820550642>3.0.CO;2-F
  contributor:
    fullname: Huffman
– volume: 60
  start-page: 955
  year: 2011
  ident: 10.1016/j.urology.2013.08.048_bib9
  article-title: Antegrade perfusion with bacillus Calmette-Guerin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit?
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2011.07.051
  contributor:
    fullname: Giannarini
– volume: 88
  start-page: 343
  year: 2001
  ident: 10.1016/j.urology.2013.08.048_bib16
  article-title: Intrarenal bacillus Calmette-Guerin therapy for carcinoma in situ of the upper urinary tract: long-term follow-up and natural course in cases of failure
  publication-title: BJU Int
  doi: 10.1046/j.1464-410X.2001.02297.x
  contributor:
    fullname: Okubo
– volume: 21
  start-page: 374
  year: 2007
  ident: 10.1016/j.urology.2013.08.048_bib17
  article-title: Setting a new standard for topical therapy of upper-tract transitional-cell carcinoma: BCG and interferon-alpha2B
  publication-title: J Endourol
  doi: 10.1089/end.2007.9969
  contributor:
    fullname: Katz
– volume: 59
  start-page: 584
  year: 2011
  ident: 10.1016/j.urology.2013.08.048_bib1
  article-title: European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2010.12.042
  contributor:
    fullname: Roupret
– volume: 85
  start-page: 799
  year: 2000
  ident: 10.1016/j.urology.2013.08.048_bib18
  article-title: Bacillus Calmette-Guerin instillation treatment for carcinoma in situ of the upper urinary tract
  publication-title: BJU Int
  doi: 10.1046/j.1464-410x.2000.00610.x
  contributor:
    fullname: Nishino
– volume: 46
  start-page: 442
  year: 2004
  ident: 10.1016/j.urology.2013.08.048_bib28
  article-title: Tumor seeding following percutaneous antegrade treatment of transitional cell carcinoma in the renal pelvis
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2004.01.021
  contributor:
    fullname: Treuthardt
– volume: 178
  start-page: 2314
  year: 2007
  ident: 10.1016/j.urology.2013.08.048_bib25
  article-title: Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update
  publication-title: J Urol
  contributor:
    fullname: Hall
– volume: 77
  start-page: 676
  year: 1996
  ident: 10.1016/j.urology.2013.08.048_bib10
  article-title: Bacillus Calmette-Guerin perfusion therapy for carcinoma in situ of the upper urinary tract
  publication-title: Br J Urol
  doi: 10.1046/j.1464-410X.1996.09559.x
  contributor:
    fullname: Yokogi
– volume: 63
  start-page: 1084
  year: 2004
  ident: 10.1016/j.urology.2013.08.048_bib12
  article-title: Long-term effects of bacille Calmette-Guerin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract
  publication-title: Urology
  doi: 10.1016/j.urology.2004.01.046
  contributor:
    fullname: Hayashida
– volume: 45
  start-page: 381
  year: 1995
  ident: 10.1016/j.urology.2013.08.048_bib6
  article-title: Definitive tumor resection and percutaneous bacille Calmette-Guerin for management of renal pelvic transitional cell carcinoma in solitary kidneys
  publication-title: Urology
  doi: 10.1016/S0090-4295(99)80005-3
  contributor:
    fullname: Vasavada
– volume: 163
  start-page: 52
  year: 2000
  ident: 10.1016/j.urology.2013.08.048_bib22
  article-title: Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach
  publication-title: J Urol
  contributor:
    fullname: Guarnizo
– volume: 172
  start-page: 2077
  year: 2004
  ident: 10.1016/j.urology.2013.08.048_bib19
  article-title: Pig kidney: anatomical relationships between the intrarenal arteries and the kidney collecting system. applied study for urological research and surgical training
  publication-title: J Urol
  contributor:
    fullname: Pereira-Sampaio
– volume: 9
  start-page: 475
  year: 2000
  ident: 10.1016/j.urology.2013.08.048_bib21
  article-title: Statistical description of interrater variability in ordinal ratings
  publication-title: Stat Methods Med Res
  doi: 10.1191/096228000701555262
  contributor:
    fullname: Nelson
– volume: 159
  start-page: 71
  year: 1998
  ident: 10.1016/j.urology.2013.08.048_bib13
  article-title: New techniques for the administration of topical adjuvant therapy after endoscopic ablation of upper urinary tract transitional cell carcinoma
  publication-title: J Urol
  contributor:
    fullname: Patel
– volume: 156
  start-page: 386
  year: 1996
  ident: 10.1016/j.urology.2013.08.048_bib29
  article-title: Fever following intracavitary bacillus Calmette-Guerin therapy for upper tract transitional cell carcinoma
  publication-title: J Urol
  contributor:
    fullname: Schnapp
– volume: 2
  start-page: 376
  year: 2005
  ident: 10.1016/j.urology.2013.08.048_bib3
  article-title: Endourologic treatment of upper urinary tract transitional cell carcinoma
  publication-title: Nat Clin Pract Urol
  doi: 10.1038/ncpuro0250
  contributor:
    fullname: Ost
– volume: 13
  start-page: 340
  year: 2006
  ident: 10.1016/j.urology.2013.08.048_bib15
  article-title: Long-term outcome of upper urinary tract carcinoma in situ: effectiveness of nephroureterectomy versus bacillus Calmette-Guerin therapy
  publication-title: Int J Urol
  doi: 10.1111/j.1442-2042.2006.01312.x
  contributor:
    fullname: Kojima
– volume: 154
  start-page: 1629
  year: 1995
  ident: 10.1016/j.urology.2013.08.048_bib5
  article-title: Percutaneous management of transitional cell carcinoma of the renal collecting system: 9-year experience
  publication-title: J Urol
  contributor:
    fullname: Jarrett
– volume: 59
  start-page: 997
  year: 2011
  ident: 10.1016/j.urology.2013.08.048_bib26
  article-title: EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2011.03.017
  contributor:
    fullname: Babjuk
– volume: 73
  start-page: 27
  year: 2009
  ident: 10.1016/j.urology.2013.08.048_bib8
  article-title: A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus Calmette Guerin therapy?
  publication-title: Urology
  doi: 10.1016/j.urology.2008.06.026
  contributor:
    fullname: Rastinehad
– volume: 145
  start-page: 842
  year: 1991
  ident: 10.1016/j.urology.2013.08.048_bib30
  article-title: Indigocarmine as a quantitative indicator of urothelial integrity
  publication-title: J Urol
  contributor:
    fullname: Monson
– volume: 59
  start-page: 53
  year: 2002
  ident: 10.1016/j.urology.2013.08.048_bib14
  article-title: Intravesical instillation of bacille Calmette-Guerin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter
  publication-title: Urology
  doi: 10.1016/S0090-4295(01)01488-1
  contributor:
    fullname: Irie
– volume: 173
  start-page: 890
  year: 2005
  ident: 10.1016/j.urology.2013.08.048_bib27
  article-title: Assessment of vesicoureteral reflux in patients with self-retaining ureteral stents: implications for upper urinary tract instillation
  publication-title: J Urol
  contributor:
    fullname: Yossepowitch
– volume: 183
  start-page: 2148
  year: 2010
  ident: 10.1016/j.urology.2013.08.048_bib23
  article-title: Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma
  publication-title: J Urol
  contributor:
    fullname: Gadzinski
– volume: 110
  start-page: 1618
  year: 2012
  ident: 10.1016/j.urology.2013.08.048_bib24
  article-title: Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients
  publication-title: BJU Int
  doi: 10.1111/j.1464-410X.2012.11066.x
  contributor:
    fullname: Grasso
– volume: 26
  start-page: 47
  year: 1985
  ident: 10.1016/j.urology.2013.08.048_bib4
  article-title: Consideration for treatment of upper urinary tract tumors with topical therapy
  publication-title: Urology
  contributor:
    fullname: Huffman
– year: 2010
  ident: 10.1016/j.urology.2013.08.048_bib20
  contributor:
    fullname: Bass
– volume: 9
  start-page: 677
  year: 2002
  ident: 10.1016/j.urology.2013.08.048_bib11
  article-title: Clinical outcome of bacillus Calmette-Guerin perfusion therapy for carcinoma in situ of the upper urinary tract
  publication-title: Int J Urol
  doi: 10.1046/j.1442-2042.2002.00551.x
  contributor:
    fullname: Miyake
– volume: 168
  start-page: 1381
  year: 2002
  ident: 10.1016/j.urology.2013.08.048_bib7
  article-title: Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery
  publication-title: J Urol
  contributor:
    fullname: Thalmann
SSID ssj0006667
Score 2.241358
Snippet Objective To evaluate the degree of urothelial exposure using 3 upper tract delivery techniques in an ex vivo porcine model, to determine the optimal modality...
To evaluate the degree of urothelial exposure using 3 upper tract delivery techniques in an ex vivo porcine model, to determine the optimal modality to locally...
To evaluate the degree of urothelial exposure using 3 upper tract delivery techniques in an ex vivo porcine model, to determine the optimal modality to locally...
OBJECTIVETo evaluate the degree of urothelial exposure using 3 upper tract delivery techniques in an ex vivo porcine model, to determine the optimal modality...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 1451.e1
SubjectTerms Administration, Topical
Animals
Anticarcinogenic Agents - administration & dosage
Coloring Agents
Disease Models, Animal
Kidney
Stents
Swine
Ureter
Urinary Catheterization - methods
Urinary Tract
Urologic Neoplasms - drug therapy
Urology
Urothelium
Title Comparison of 3 Upper Tract Anticarcinogenic Agent Delivery Techniques in an Ex Vivo Porcine Model
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0090429513011321
https://dx.doi.org/10.1016/j.urology.2013.08.048
https://www.ncbi.nlm.nih.gov/pubmed/24139525
https://search.proquest.com/docview/1464888904
Volume 82
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEF5SB0ovJX07acMGepUt7UOPo3ET3JSEHuyS27LaHYFCkIxlh-SS35Lfkl-WHWnlUNpSyFFCw0qzszOjmflmCPmaA3AdsyzQYcYCAZYHecJMANIWoS6MjNuA29l5PFuI0wt5sUOmPRYGyyq97u90equt_Z2x5-Z4WZaI8c1Qm8oIZZQjmHzXmSOWDsju5PuP2flWITsP3bfODAMkeALyjC9Hm1UbvsYiL94288RJQH83Uf9yQVtTdLJHXnsfkk6613xDdqB6S16e-Sz5O2Km2-GCtC4op4vlElZ0joAoOqkwer1yT9ZOdkpDJwiuot_gCis0bum8b-ra0LKiuqLHNw_3v8rrmv6skQoojk-7ek8WJ8fz6SzwwxQCI1i4DpxblwHkwkkOTxOW6gRikcTGpghuFbExMtKYAzWptsBAauc8hNwU0orEeUn8AxlUdQWfCM1CG4VFLphmRkhRaJEbzfPCxhaS3KZDMur5p5ZdzwzVF5NdKs9whQxXOAJTOIKk57LqAaFOhUHjz1OjItUwFao_9nxI0i3lb2KjnEX436JH_X4qd6QwT6IrqDcN_g05tZa6lYbkY7fR2-_ANGQmmdx__sIH5BVedTUxn8lgvdrAF-fZrPND8mJ0Fx16-X0ELEf5QQ
link.rule.ids 315,783,787,4509,24128,27936,27937,45597,45691
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDBaKFth2Kbru0bTbqgG9unH08OMYZC3SR4IekqE3QZZowEVhB3FStP-mv2W_bKItZxi2YUCvtgnZFEV9FvmRhJxkAFxHLA10mLJAgOVBFjMTgLR5qHMjo-bAbTKNxnNxeStvt8io48JgWqX3_a1Pb7y1v9L32uwvigI5vil6UzlAG-VIJt9xaCB1q3NneHE1nm4cskPovnRmGKDALyJP_-50vWyOrzHJizfFPLET0N-3qH9B0GYrOt8jux5D0mH7mm_JFpT75NXER8nfETPaNBekVU45nS8WsKQzJETRYYmn10v3ZOVspzB0iOQq-g3uMUPjic66oq41LUqqS3r2-OP5e_FQ0ZsKpYBi-7T792R-fjYbjQPfTCEwgoWrwMG6FCATznJ4ErNExxCJODI2QXKriIyRA40xUJNoCwykduAh5CaXVsQOJfEPZLusSjggNA3tIMwzwTQzQopci8xonuU2shBnNumR005_atHWzFBdMtmd8gpXqHCFLTCFE4g7LauOEOpcGNR-PdVqoGqmQvXHnPdIspH8zWyU2xH-N-jXbj6VW1IYJ9ElVOsa_4acW0vcSD3ysZ3ozXdgGDKVTB6-fOBj8no8m1yr64vp1RF5g3fa_JhPZHu1XMNnh3JW2RdvxT8BM9b7NQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+3+upper+tract+anticarcinogenic+agent+delivery+techniques+in+an+ex+vivo+porcine+model&rft.jtitle=Urology+%28Ridgewood%2C+N.J.%29&rft.au=Pollard%2C+Matthew+E&rft.au=Levinson%2C+Adam+W&rft.au=Shapiro%2C+Edan+Y&rft.au=Cha%2C+Doh+Y&rft.date=2013-12-01&rft.eissn=1527-9995&rft.volume=82&rft.issue=6&rft.spage=1451.e1&rft.epage=1451.e6&rft_id=info:doi/10.1016%2Fj.urology.2013.08.048&rft.externalDBID=NO_FULL_TEXT
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00904295%2FS0090429513X00111%2Fcov150h.gif